Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

androgenetic alopecia - Clinical Profile, Treatments & Trials | Kisho | Kisho

Rare Disease

androgenetic alopecia

MONDO:0005339

Also known as:alopecia androgenetica, male pattern baldnessmale pattern baldnessandrogenic alopecia

Find Clinical TrialsTrials

Overview

Treatments1 FDA approved

Clinical Trials64 registered · 20 recruiting

Diagnosis

Biomarker and diagnostic research for androgenetic alopecia has been reported in the published literature.

Treatment

Compiled from FDA-approved drug records, orphan drug designations, and FDA Adverse Event Reporting System (FAERS) safety data. GeneReviews management guidance is included where available.

1 FDA-approved treatment is available for androgenetic alopecia, including FINASTERIDE (PROPECIA, approved 1997).

Approved Therapies

Brand Name	Generic Name	Mechanism	Approved	Market Status

Research Landscape

Sourced from ClinicalTrials.gov and PubMed. Publication types are classified using NLM-curated article metadata; research type breakdowns reflect the nature of published work for this disease.

64 clinical trials registered, 20 recruiting. Interventions under study include drug therapy, other interventions, medical devices, and procedural interventions. Pipeline includes 2 PHASE4, 13 PHASE3, 9 PHASE2. Research is sponsored by a mix of industry and academic institutions.

NCT ID	Title	Phase	Sponsor	Status
[NCT07429253](https://clinicaltrials.gov/study/NCT07429253)

Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 6:00 AM UTC

MONDOHPOClinicalTrials.govFDAPubMedHGNCClinVarClinGenGeneReviewsOrphanetOMIMRUSP

Medical References

External Resources

GARD

Genetic and Rare Diseases Info Center

GARD:9269

Questions for Your Care Team

→What are the benefits and potential side effects of PROPECIA for managing androgenetic alopecia?
→Are any of the 64 active clinical trials a good fit for my situation?
→Are there specialists or centers of excellence for this condition in my area?
→Is there a patient registry I should consider joining?

← Back to All Diseases

Research Type	Count	% of Total
Research summaries	77	32%
Laboratory research	46	19%
Clinical study results	35	15%
Disease patterns and progression	32	13%
New treatment approaches	24	10%
Other research	14	6%
Patient case studies	7	3%
Testing and diagnosis research	6	2%

androgenetic alopecia

Overview

Diagnosis

Treatment

Approved Therapies

Research Landscape

Medical References

External Resources

GARD

Related Diseases

Questions for Your Care Team

Questions for Your Care Team

Clinical Trials

Recent Publications